Unicycive Therapeutics, Inc. (UNCY) Misses Q3 EPS by 9c

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q3 EPS of ($0.37), $0.09 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $951 thousand.

For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target